Related by context. All words. (Click for frequent words.) 62 generation purine nucleoside 60 PN# [001] 60 R#/MEM # 60 LX# [003] 60 Oral NKTR 60 Tasimelteon 59 MoxDuo 59 GV# [001] 59 Tyrima 59 MAP# 59 ALGRX 58 GAMMAGARD 58 diabetic neuropathic pain 58 NGX# 58 MB# [004] 58 Phase IIa trials 58 Pimavanserin 58 selective androgen receptor modulator 58 PRX # 58 nitric oxide donating prostaglandin 58 peripherally acting 57 DG# [001] 57 TRC# 57 TxDAC 57 RF amplifier 57 SNRI 57 liposomal formulation 57 tezampanel 57 Apoptone 57 VA# [002] 57 vidofludimus 57 quadrature modulators 57 subcutaneously administered 57 dyskinesia PD LID 57 PRT# 57 PDE4 inhibitor 57 INT# [002] 57 intranasal formulation 57 DB# [003] 56 metaglidasen 56 MoxDuo ® 56 selective antagonist 56 JAK inhibitor 56 AR# [001] 56 TAS# [001] 56 Mipomersen 56 synchronous buck converter 56 TriRima 56 MICRF# 56 davalintide 56 oral prodrug 56 bazedoxifene selective estrogen receptor 56 mTOR inhibitor 56 MKC# MKC# PP 56 Traficet EN 56 investigational drug 56 ADRF# 56 pharmacologically active isomer 56 Phase 1a clinical 56 ARC# [002] 56 Elagolix 56 ADP receptor antagonist 56 Bicifadine 56 zonisamide SR 56 PWM controller 56 modulator 56 investigational oral 56 MoxDuo TM IR 56 TRF# [002] 55 AEG# 55 Methylnaltrexone 55 teriflunomide 55 OPA# [002] 55 xanthine oxidase inhibitor 55 UCC# 55 HuMax EGFr 55 generation antisense 55 novel prodrug 55 ARX# [001] 55 TG# [003] 55 active comparator 55 evaluating tivozanib 55 6R BH4 55 transimpedance amplifier 55 mu opioid receptor antagonist 55 mertansine 55 Vilazodone 55 serotonin norepinephrine reuptake inhibitor 55 inhaled formulation 55 HCV protease inhibitor 55 PI3K/mTOR 55 subcutaneous formulation 55 ATL# [002] 55 TH# [003] 55 ADN# 55 E2F Decoy 55 Xanafide 55 orally administered inhibitor 55 Archexin 55 ADA# 55 investigational humanized monoclonal antibody 55 CG# [001] 55 modulators SERMs 55 prescribed proton pump 54 ANCHOR trial 54 desvenlafaxine succinate 54 phase IIa clinical 54 aldehyde dehydrogenase ALDH2 deficiency 54 TBC# 54 somatostatin analogue 54 oral rivaroxaban 54 mcg doses 54 SERMs 54 BCX# 54 opioid receptor antagonist 54 TLK# 54 BAY #-# 54 orally bioavailable 54 blind placebo 54 CCR5 antagonist 54 tapentadol ER 54 epothilone 54 sublingual formulation 54 uricase 54 mTOR inhibitors 54 baseband IC 54 mGluR5 negative 54 CG# [003] 54 sodium glucose cotransporter 54 albiglutide 54 TELCYTA 54 dexpramipexole 54 STLC# 54 AT# [001] 54 TAT# 54 TRIOLEX 54 Phase 2b clinical trials 54 trospium 54 efficacy endpoint 54 PS# [001] 54 potent topoisomerase II 54 prospective randomized multicenter 54 EDEMA3 54 thorough QT 54 RhuDex ® 54 Q#IR 54 Soliris eculizumab 54 tasocitinib 54 tarenflurbil 54 desvenlafaxine 54 ADX# 54 selective estrogen receptor 54 PSN# [002] 54 prucalopride 54 regorafenib 54 INCB# [001] 54 Phenoptin 54 TRO# 54 deserializer 54 controlled multicenter 54 local oscillator LO 54 Bruton tyrosine kinase Btk 54 lomitapide 53 MoxDuo IR 53 dose regimens 53 DU #b 53 irbesartan 53 Triolex 53 DG# [003] 53 SCH # 53 GSK# [002] 53 SAW filter 53 immunomodulatory therapy 53 macrolide antibiotic 53 RFR# 53 frequency synthesizer 53 cortisol synthesis 53 EZN 53 RLY# 53 visilizumab 53 AZILECT R 53 AWL# 53 pharmacodynamics PD 53 pulse width modulation 53 IAP inhibitor 53 Deadlinepix 53 EOquin 53 SGLT2 inhibitors 53 volociximab 53 adipiplon 53 Dapagliflozin 53 CYT# potent vascular disrupting 53 LTM# 53 rNAPc2 53 PNP inhibitor 53 ATL# [001] 53 docetaxel Taxotere ® 53 Sapacitabine 53 tiapamil 53 pain palliation 53 ISL# [001] 53 bupropion SR 53 alvespimycin 53 INT# [001] 53 Golimumab 53 Naproxcinod 53 CEQ# 53 EPC# 53 highly selective endothelin 53 renin inhibitor 53 ulimorelin 53 Si#x 53 efficacy tolerability 53 MEK inhibitor 53 THS# 53 oral anticoagulant 53 XL# XL# XL# 53 CLC# 53 THR beta agonist 53 Lubiprostone 53 vascular disrupting agent 53 ASTEROID 53 AD#x 53 Linaclotide 53 Panzem R 53 tanespimycin 53 PI3K inhibitor 53 MAX#/MAX# [002] 53 PREZISTA r 53 pharmacodynamic properties 53 refractory gout 53 RG# [001] 53 CIMZIA TM 53 TRX# 53 muraglitazar 53 receptor blocker 53 HGS# 53 nucleoside reverse transcriptase inhibitor 53 Dabigatran etexilate 53 phase IIb clinical 53 SLx 53 instrumentation amplifiers 53 fosbretabulin 53 administered subcutaneously 53 DUROS 53 modulator SERM 53 Wolfson WM# 53 LNAs 53 Laquinimod 53 ISL#A 53 inhibitor PPI 53 antiplatelet compound 53 JAK2 inhibitor 53 cangrelor 53 Si# [001] 53 Vaprisol 52 5 HT2A receptor 52 anticancer compound 52 BRIM2 52 #MHz bandwidth 52 Si#DB 52 protein kinase inhibitor 52 TNF alpha inhibitor 52 downconverter 52 Tarceva TM 52 CA4P 52 elotuzumab 52 Tekturna HCT 52 5 HT2C receptor 52 ICA # 52 PEG SN# 52 Protelos 52 Synavive 52 Sym# 52 atrasentan 52 ELND# 52 Locteron 52 riociguat 52 rFIXFc 52 HQK 52 urate lowering 52 ALN TTR 52 favorable pharmacokinetic profile 52 salmeterol fluticasone 52 Elvitegravir 52 arterial thrombosis 52 Preclinical studies suggest 52 phase IIa 52 TNF Tumor Necrosis Factor 52 renin inhibitors 52 lurasidone 52 Solulin 52 FOD# 52 MDV# 52 iCoupler 52 integrase inhibitor 52 ritonavir boosted 52 TDA# [001] 52 multicenter randomized placebo controlled 52 diplexer 52 transceiver IC 52 corticosteroid dexamethasone 52 Carfilzomib 52 CIMZIA ™ 52 CCX# 52 EDFAs 52 buck converter 52 MIRCERA 52 oral Factor Xa 52 TMC# [002] 52 antithrombotic 52 novel topoisomerase 52 pharmacodynamic profile 52 CDK inhibitor 52 aripiprazole Abilify 52 viral kinetic 52 ADF# 52 ISL# [002] 52 AOZ# 52 alagebrium 52 ULORIC 52 NET# [002] 52 Cleviprex TM clevidipine 52 PDE4 inhibitors 52 delta sigma 52 CCR9 antagonist 52 dose dose escalation 52 multicenter Phase II 52 MoxDuo ® IR 52 reslizumab 52 Stratix II FPGAs 52 op amp 52 nalbuphine ER 52 APTIVUS 52 DAN# 52 MAX# [003] 52 virus HCV protease inhibitor 52 quadrature modulator 52 nucleotide analog 52 Ganciclovir 52 PWM pulse width modulation 52 antiplatelet agent 52 adenosine injection 52 investigational pharmacologically unique 52 fenofibric acid 52 glufosfamide 52 IMiDs 52 ZMD# 52 elvitegravir 52 pramlintide metreleptin combination 52 Dasatinib 52 QT QTc 52 trodusquemine 52 ZOLINZA 52 HMC#LP#E 52 mild vasodilator 52 CORT # 52 Safinamide 52 analgesic efficacy 52 ocular formulation 52 mg dose 52 receptor partial agonist 52 LX# LX# 52 CIMZIA TM certolizumab pegol 52 sampling oscilloscope 52 MTP inhibitor 52 pan HDAC inhibitor 52 CX# [001] 52 octreotide acetate 52 lacosamide 52 ADuM# 52 receptor agonist 52 HuLuc# 52 triplexer 52 Arria GX FPGAs 52 Virtex 5 52 receptor antagonists 52 CHAMPION PCI 51 edifoligide 51 ISENTRESS 51 STA# [001] 51 pomalidomide 51 pegylated interferons 51 locked loop PLL 51 transceiver modules 51 Lisofylline LSF 51 AWM# 51 subcutaneous dosing 51 GLYX 51 seliciclib CYC# 51 orally dosed 51 SinuNase TM 51 LDO regulator 51 PN# [003] 51 carbidopa levodopa 51 pharmacokinetics PK 51 CYC# 51 REMINYL ® 51 Androxal TM 51 HCV protease inhibitors 51 F#x [002] 51 selective modulator 51 Sitagliptin 51 oral Janus kinase 51 TLV#AIC# 51 insulin sensitizers 51 angiotensin receptor blocker ARB 51 dopamine partial agonist 51 Anticalin ® 51 ELND-#/AZD-# 51 EP# [003] 51 trans impedance 51 direct renin inhibitor 51 LY# [003] 51 PD# [005] 51 COMT inhibitors 51 Analog Devices AD# 51 SARMs 51 #G DQPSK 51 Zoraxel TM 51 obatoclax 51 Tezampanel 51 SAR ADC 51 SiT# 51 allosteric modulator NAM 51 IRF# 51 Tesetaxel 51 Voreloxin 51 velafermin 51 PRIMO CABG 51 synchronous rectification 51 Hycamtin ® 51 investigational monoclonal antibody 51 Phase IIIb 51 apremilast 51 Tofacitinib 51 IMA# 51 Imprime PGG 51 tablet formulation 51 Hsp# Inhibitor 51 #mg doses [002] 51 GW# [003] 51 Atrasentan 51 AMIS # 51 COREG CR 51 PMBus compliant 51 Androgel R 51 febuxostat 51 Phase Ib clinical 51 AVE# 51 REG1 51 trial evaluating PRX# 51 NRTI 51 pharmacokinetic profile 51 nab paclitaxel 51 Rotigotine 51 Vicriviroc 51 Azedra 51 ARB telmisartan 51 sargramostim 51 receptor antagonist 51 PRO# [003] 51 reversible inhibitor 51 anti arrhythmic 51 PDX pralatrexate 51 LymphoStat B belimumab 51 rilpivirine 51 pulse width modulation PWM 51 transceiver module 51 bosentan 51 ENMD # 51 Nav#.# 51 Omacetaxine mepesuccinate 51 antiarrhythmic 51 glatiramer acetate Copaxone 51 Keppra XR 51 rFVIIIFc 51 polymerase inhibitor 51 anti aliasing filters 51 divalproex sodium 51 isoPower 51 LDMOS 51 prospective multicenter randomized 51 levodopa carbidopa 51 2 methoxyestradiol 51 STM# [002] 51 oral renin inhibitor 51 Tolvaptan 51 investigational compound 51 selectively binds 51 myelofibrosis polycythemia vera 51 cediranib 51 pertuzumab 51 PEGylated anti 51 XmAb# 51 mosfet 51 mGluR2 NAM 51 BENICAR HCT 51 Telmisartan 51 docetaxel chemotherapy 51 sigma delta 51 zonisamide 51 BC# [003] 51 Elesclomol 51 dihydrochloride 51 dose titration 51 pharmacokinetic PK profile 51 synchronous rectifier 51 LDMOS devices 51 ADMP# 51 CMOS RF transceiver 51 rHuPH# 51 receptor agonists 51 ganetespib 51 RFX# 51 monolithic microwave integrated 51 PrevOnco ™ 51 EndoTAG TM -1 51 PRISTIQ 51 TELINTRA 51 Phase 2a Study 51 MAX# integrates 51 LCP AtorFen 50 mesalazine 50 JAK1 50 statin simvastatin 50 histone deacetylase HDAC 50 GHz RF transceiver 50 differential amplifier 50 Ambrisentan 50 systemically administered 50 guanfacine 50 novel VDA molecule 50 neuroprotective properties 50 intravenous IV infusion 50 Differential Quadrature Phase 50 tapentadol IR 50 nRF#AP# 50 TNF inhibitor 50 IF amplifier 50 huC# DM4 50 R roscovitine 50 Exforge HCT 50 LNA 50 NN# [001] 50 PI3K/Akt pathway inhibitor 50 AV# [003] 50 CTAP# Capsules 50 ADV# [001] 50 coadministration 50 Renin inhibitors 50 Fidaxomicin 50 MAX# MAX# [001] 50 CD3 monoclonal antibody 50 nucleoside analog 50 vascular disrupting agents 50 Resten NG 50 tecarfarin 50 AEL# 50 MMX mesalamine 50 MCP# [004] 50 beta2 agonist 50 selective agonist 50 LAF# 50 intravenously administered 50 regulator LDO 50 antisense drug 50 TRV# [001] 50 Aurora Kinase 50 dasatinib Sprycel ® 50 MYDICAR ® 50 LMV# 50 NS# [003] 50 Aliskiren 50 pharmacokinetic profiles 50 laropiprant 50 ISIS # 50 DACH platinum 50 EP# [005] 50 pegnivacogin 50 proteasome inhibitor 50 CONVERTERS 50 #dBc 50 NCP# [001] 50 IRX 2 50 QTc prolongation 50 insulin sensitizer 50 NV1FGF 50 ADM# 50 ADC#D# 50 Atripla combines 50 vicriviroc 50 #:# multiplexer 50 AS# amonafide L malate 50 biologic DMARD 50 DMOS 50 tocilizumab 50 Digital Converter ADC 50 melphalan prednisone 50 Cloretazine 50 aflibercept 50 RF#x 50 #bit ADC 50 PEGylated Fab fragment 50 Onalta 50 MIC#/# 50 Rezular 50 CYP#A# CYP#D# 50 MYDICAR 50 mecamylamine 50 MLN# 50 clomipramine 50 clobazam 50 TPS# [002] 50 teduglutide 50 ALN TTR# 50 S/GSK# 50 ESBA# 50 clevidipine 50 pharmacodynamic PD 50 cathepsin K inhibitor 50 Schottky diode 50 M6G 50 adalimumab Humira 50 Ramelteon 50 FAN# [002] 50 BiFET 50 urinary N telopeptide 50 quiescent current 50 Fenretinide 50 baseband LSI 50 Squalamine 50 LY# [002] 50 Ecallantide 50 intradermal injection 50 glycoprotein IIb IIIa inhibitor 50 multicenter randomized double 50 #mg BID [003] 50 ApoB SNALP 50 achieved statistical significance 50 Orazol 50 aliskiren 50 pharmacodynamic endpoints 50 IIIa inhibitor 50 investigational pan BCR 50 ADCs DACs 50 LIALDA 50 ROCKET AF 50 preclinical efficacy 50 DPP4 inhibitor 50 varactors 50 3 kinase PI3K 50 Solazed TM 50 SPC# [001] 50 XP# XP# 50 digital isolator 50 immunotherapeutic agent 50 DLTs 50 optocoupler 50 CAT# [002] 50 dc dc controller 50 AT# [002] 50 CBLC# 50 RF IC 50 angiogenesis inhibitor 50 DXL# 50 digitally programmable 50 Microplasmin 50 0dBm 50 echinocandin 50 ularitide 50 Aptivus ® 50 MEK inhibitors 50 Afatinib 50 BENICAR 50 antiarrhythmic drug 50 ALN PCS 50 SGLT2 inhibitor 50 Altera Stratix II 50 proteasome inhibitors 50 SKY# #LF 50 factor Xa 50 Enkephalin 50 entacapone 50 JANUVIA 50 JAK#/JAK# 50 Cloretazine VNP#M 50 Vitesse FlexEQ 50 DirectFET R 50 small molecule glucokinase 50 FOLOTYN ® 50 Ocrelizumab 50 Vidofludimus 50 OncoVEX GM CSF 50 PARI Pharma GmbH 50 VCO PLL 50 APTIVUS r 50 abacavir lamivudine 49 LH RH 49 amplifier module 49 Ereska 49 SNT MC# 49 Ampakine 49 TRF# [001] 49 Aflibercept 49 eprotirome 49 LM# [003] 49 Alfimeprase 49 anti angiogenic agent 49 oral FTY# 49 PEGylated interferon beta 1a 49 aurora kinase 49 XYOTAX TM 49 op amps 49 Elitek 49 LHRH antagonists 49 Broadcom BCM# [001] 49 MOSFETS 49 instrumentation amplifier 49 Agilent #A [001] 49 DAC# 49 Polymer Microspheres 49 dosage regimens 49 glucagon receptor 49 placebo controlled randomized 49 APOPTONE 49 IEPE 49 L PPDS 49 Zoloft sertraline 49 oral proteasome inhibitor 49 arbitrary waveform generator 49 Survivin antagonist 49 paclitaxel Taxol 49 CANCIDAS 49 duplexers 49 #mOhm 49 platelet inhibitor 49 ARM#JF S 49 noise amplifier LNA 49 mg kg dose 49 esomeprazole 49 Zarlink ZL# 49 ruxolitinib 49 EOquin TM 49 Protein Kinase C 49 Zenvia Phase III 49 relapsing multiple sclerosis 49 protease inhibitor PI 49 DURECT proprietary 49 Daclizumab 49 MIC# [002] 49 humanized monoclonal antibody 49 MAX#A 49 #nm VCSEL [001] 49 ZL# [003] 49 RH1 49 Model #A 49 MEK inhibitor RDEA# 49 radiation sensitizer 49 ProSavin 49 ancrod 49 TMC# [001] 49 TPI ASM8 49 Rilonacept 49 hypoxia selective 49 iroxanadine 49 Tanespimycin 49 DP b# 49 HE# [002] 49 nicardipine 49 Dalbavancin 49 sevelamer carbonate 49 intermittent dosing 49 PEGPH# 49 ADXRS# 49 PIC#F# [002] 49 Symadex 49 Boceprevir 49 tenofovir Viread 49 DepoDur TM 49 Ixempra 49 RezularTM 49 AAT# 49 Eculizumab 49 Amrubicin 49 PF # [001] 49 Annamycin 49 maximal dose 49 Edarbi 49 noise amplifiers LNAs 49 SP#E 49 Apixaban 49 SAW filters 49 AG# [003] 49 dc converter 49 HVIC 49 GaAs pHEMT 49 r hGH 49 2DG 49 sitagliptin 49 ZX# [001] 49 TCI# 49 boosted protease inhibitor 49 ranolazine 49 amifampridine phosphate 49 novel synthetic peptide 49 partial agonist 49 MIC# [003] 49 GL# [003] 49 ATR# [002] 49 I2C interface 49 radezolid 49 continuous intravenous infusion 49 TLR9 agonist 49 rilonacept 49 hyperphenylalaninemia HPA due 49 palonosetron 49 Noxafil 49 Torisel 49 XFP MSA 49 ISL#E [001] 49 ZL# device 49 Abbokinase 49 KB# [002] 49 ascending dose 49 FFNS 49 prospective multicenter 49 HMC C# 49 erlotinib Tarceva ® 49 VAPRISOL 49 SPI interface 49 subcutaneous insulin 49 oxcarbazepine 49 VCOs 49 MB# MB# 49 intensive lipid lowering 49 subcutaneous SC 49 esomeprazole Nexium 49 Chemokine Receptor 49 selectively inhibit 49 pharmacokinetic interactions 49 insulin detemir 49 Angiotensin Converting Enzyme 49 cobicistat 49 secondary efficacy endpoints 49 C# DSP 49 #.#x#.#mm 49 GN# [002] 49 EZRadioPRO 49 Pertuzumab 49 nucleoside analogue 49 VMMK #x# 49 catheter occlusion 49 amplifier PA 49 tigecycline 49 AZD# 49 PIN photodiode 49 AWT# 49 overvoltage protection OVP 49 humanized anti 49 SKY# 49 Proellex TM 49 Humalog ® 49 eszopiclone 49 Blinatumomab 49 Factor VIIa 49 factor Xa inhibitors 49 goserelin 49 signal transduction inhibitor 49 MOSFET gate 49 Eltrombopag 49 mA output 49 LT# [003] 49 GPS GLONASS 49 5 HT3 receptor 49 acute peripheral arterial 49 Ceplene/IL-2 49 AST ALT 49 bile acid sequestrant 49 P#X# 49 bit sigma delta 49 mTOR kinase 49 SiP# 49 Solazed ™ 49 Histalean TM 49 DexaSite 49 QPSK 49 canakinumab 49 MAX# [001] 49 posaconazole 49 MMA#Q 49 Phase III randomized controlled 49 occlusion PAO 49 octreotide LAR 49 Stratix IV GX FPGAs 49 epigenetic therapies 49 phototransistors 49 ALVESCO R 49 LNP formulations 49 tunable RF 49 iT# 49 bucindolol hydrochloride 49 8PSK 49 sulphonylureas 49 Candesartan 49 VCXO 49 Muraglitazar 48 multicentre randomized 48 Anticalin R 48 saline placebo 48 epothilones 48 mRNA antagonists 48 #.#GHz [001] 48 CERVARIX 48 XOPENEX HFA 48 bexarotene 48 Darunavir 48 Hsp# inhibitor 48 reverse transcriptase inhibitor 48 basal insulin 48 AWB# 48 crizotinib PF # 48 Chipcon CC# 48 COPEGUS 48 GaAs MMIC 48 enzyme cofactor 48 Orally administered 48 serializer deserializer 48 STV# 48 PHY# [001] 48 5 HT3 antagonist 48 BRAF kinase 48 ALVESCO 48 #D#C# 48 RP# [002] 48 include PLX IBD 48 Raltegravir 48 VELCADE melphalan 48 HCV RESPOND 2 48 rosuvastatin #mg 48 Myolimus 48 BXT # 48 tumor xenograft models 48 beta Estradiol 48 darunavir ritonavir 48 lock loop PLL 48 MF# [002] 48 Omiganan 48 Interferon beta 1a 48 aspirin clopidogrel 48 demodulator 48 Atacand 48 TMC# r 48 Akt inhibitor 48 BN# [002] 48 lapatinib Tykerb 48 bandpass filter 48 estramustine 48 venlafaxine XR 48 ML# [001] 48 antiresorptive 48 olmesartan 48 HepDirect prodrug 48 internal RC oscillator 48 mg QD 48 VIAject ™ 48 paricalcitol 48 ABC/3TC 48 idraparinux 48 Hsp# inhibitors 48 thromboxane A2 48 ME# [002] 48 TQM#M# 48 PIN diode 48 prospective randomized placebo 48 cetuximab Erbitux ® 48 MAX#/MAX# [001] 48 SRT# [003] 48 rFVIIa 48 highly selective inhibitor 48 candesartan cilexetil 48 RDS ON 48 #.#μm CMOS 48 timolol 48 transceiver 48 Factor Xa inhibitor 48 IFN α 48 PLK1 SNALP 48 acetylcholinesterase AChE 48 anti amnesic 48 ZACTIMA 48 RF transceiver 48 #mg dose [001] 48 HMG CoA reductase inhibitor 48 PLL synthesizer 48 antithrombotics 48 oral deforolimus 48 Ripcord2 48 ALV#